Phase Genomics raised $1.5M in funding led by Bill & Melinda Gates Foundation to develop a new antimicrobial discovery platform.

Mar 05, 2024•almost 2 years ago

Amount Raised

$1.5 Million

Round Type

seed

SeattleScience And EngineeringData And Analytics

Investors

Bill & Melinda Gates Foundation

Description

Phase Genomics, a genomics technology development company based in Seattle, WA, raised $1.5M in funding. The funding was provided by the Bill & Melinda Gates Foundation. The company intends to use the funds to develop a new antimicrobial discovery platform.

Company Information

Company

Phase Genomics

Location

4000 MASON ROAD

Seattle, Washington, United States

About

Phase Genomics applies proprietary ultra-long-range genome sequencing technology to enable genome assembly, microbiome discovery, as well as analysis of genomic integrity and chromosomal aberrations. In addition to a comprehensive portfolio of laboratory and computational services and products, including reagent kits and genomic services, they also offer an industry-leading genome and metagenome assembly and analysis software. Based in Seattle, WA, the company was founded in 2015 by a team of genome scientists, software engineers, and entrepreneurs. The company’s mission is to empower scientists with genomic tools that accelerate breakthrough discoveries.

Related People

3 contacts

Funding Insights

Based on industry data

VC-backed spending patterns